About SYNLAB
SYNLAB is a company based in Munchen (Germany) founded in 1998 was acquired by Cinven in June 2015.. The company has 28,693 employees as of December 31, 2022. SYNLAB has completed 11 acquisitions, including Belluno Medica, Cityterveys and Igea Sant Antimo. SYNLAB operates in a competitive market with competitors including Natera, Progenity, Beikang Medical, Yourgene Health and Sequenom, among others.
- Headquarter Munchen, Germany
- Employees 28693 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Synlab International Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$1.8 M (USD), Grant
Dec 31, 2016
-
Investors
European Union
& 4 more
-
Employee Count
28693
as on Dec 31, 2022
-
Investments & Acquisitions
Belluno Medica
& 10 more
-
Acquired by
Cinven
(Jun 25, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of SYNLAB
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $1.8M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2016 | Amount | Grant - SYNLAB | Valuation |
investors |
|
| Sep, 2016 | Amount | Grant - SYNLAB | Valuation |
investors |
|
| Feb, 2016 | Amount | Series A - SYNLAB | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SYNLAB
SYNLAB has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, BC Partners and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Founded Year | Domain | Location | |
|
Diversified alternative assets are managed through investment strategies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SYNLAB
SYNLAB has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Belluno Medica, Cityterveys and Igea Sant Antimo. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Standalone general clinic
|
2015 | ||||
|
Standalone radiology & pathology laboratory center
|
2015 | ||||
|
Limited information available
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - SYNLAB
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Synlab Comparisons
Competitors of SYNLAB
SYNLAB operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, Progenity, Beikang Medical, Yourgene Health and Sequenom, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| domain | founded_year | HQ Location |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genetic tests and genomic services are provided.
|
|
| domain | founded_year | HQ Location |
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Synlab
Frequently Asked Questions about SYNLAB
When was SYNLAB founded?
SYNLAB was founded in 1998 and raised its 1st funding round 11 years after it was founded.
Where is SYNLAB located?
SYNLAB is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Who is the current CEO of SYNLAB?
Mathieu Floreani is the current CEO of SYNLAB.
How many employees does SYNLAB have?
As of Dec 31, 2022, the latest employee count at SYNLAB is 28,693.
What does SYNLAB do?
SYNLAB was founded in 1998 and is headquartered in Munich, Germany. Operations are conducted in the medical diagnostics sector, with a focus on clinical laboratory analysis. Services encompass various diagnostic categories through an advanced network spanning Europe and beyond. A workforce of over 28,000 employees, including medical experts, supports these activities. The company maintains a global presence to serve customer needs in laboratory testing.
Who are the top competitors of SYNLAB?
SYNLAB's top competitors include Natera, IdentifAI and Beikang Medical.
How many acquisitions has SYNLAB made?
SYNLAB has made 11 acquisitions, including Belluno Medica, Cityterveys, and Igea Sant Antimo.
Who are SYNLAB's investors?
SYNLAB has 5 investors. Key investors include European Union, BC Partners, EIC Fund, Novo Holdings, and Cinven.